Sergio García Fernández

Associate Professor

Universidad de Cantabria

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Microbiology Microbiology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sergio García Fernández is an Associate Professor at Universidad de Cantabria, Spain. His research focuses on antibiotic resistance, particularly in Enterobacterales and Pseudomonas aeruginosa, along with methodologies for accurate detection of carbapenemases. Recent publications include investigations into the efficacy of novel antibiotic combinations and rapid diagnostic assays, contributing significantly to the understanding of resistance mechanisms in clinical settings.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Marta Hernández-García

Instituto Ramón y Cajal de Investigación Sanitaria

SPAIN

View details

Concha Ortiz Cartagena

Instituto de Investigación Biomédica de A Coruña

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sergio García Fernández

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Activity of imipenem/relebactam against Enterobacterales and Pseudomonas aeruginosa in Spain. SMART 2016-2020,Actividad de imipenem/relebactam frente a Enterobacterales y Pseudomonas aeruginosa en España. SMART 2016-2020

Are GES carbapenemases underdiagnosed? An allelic discrimination assay for their accurate detection and differentiation

CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases

Usefulness of EUCAST rapid antibiotic susceptibility breakpoints and screening cut-off values directly from blood cultures for the inference of β-lactam resistance mechanisms in Enterobacterales

In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies)

Evaluation of the rapid antigen detection test STANDARD F COVID-19 Ag FIA for diagnosing SARS-CoV-2: experience from an Emergency Department

Rapid identification from rectal swabs of the clinically most relevant carbapenemase genes from gram-negative bacteria using the BD MAX Check-Points CPO Assay

Usefulness of Fecal Calprotectin in the Management of Patients with Toxigenic <i>Clostridioides difficile</i>

Challenges of landscaping and modulation strategies in human intestinal microbiota,Desafíos para la caracterización y estrategias de la modulación en la microbiota intestinal humana

Confronting Ceftolozane-Tazobactam Susceptibility in Multidrug-Resistant Enterobacterales Isolates and Whole-Genome Sequencing Results (STEP Study)

Collaborators (2)

Marta Hernández-García

Concha Ortiz Cartagena

Make your next move.